551 related articles for article (PubMed ID: 1796226)
21. Schistosoma mansoni: immunoreactivity of human sera with the surface antigen Sm23.
Köster B; Hall MR; Strand M
Exp Parasitol; 1993 Nov; 77(3):282-94. PubMed ID: 8224084
[TBL] [Abstract][Full Text] [Related]
22. The effect of praziquantel on the circulating antigen SJ 70 in murine schistosomiasis japonica.
Carter CE; Fu C; Colley DG
Am J Trop Med Hyg; 1990 Apr; 42(4):342-6. PubMed ID: 2109949
[TBL] [Abstract][Full Text] [Related]
23. Schistosome antigen gp50 is responsible for serological cross-reactivity with Trichinella spiralis.
Linder E; Thors C; Lundin L; Ljungström I; Farah S; Hagi H; Dias F
J Parasitol; 1992 Dec; 78(6):999-1005. PubMed ID: 1491314
[TBL] [Abstract][Full Text] [Related]
24. Regression of hepatic lesions after treatment of Schistosoma mansoni or Schistosoma japonicum infection in mice: a comparative study.
Andrade ZA; Cox TM; Cheever AM
Am J Trop Med Hyg; 1993 Jul; 49(1):1-9. PubMed ID: 8352381
[TBL] [Abstract][Full Text] [Related]
25. Adult schistosome cDNA libraries as a source of antigens for the study of experimental and human schistosomiasis.
Knight M; Simpson AJ; Bickle Q; Hagan P; Moloney A; Wilkins A; Smithers SR
Mol Biochem Parasitol; 1986 Feb; 18(2):235-53. PubMed ID: 2938004
[TBL] [Abstract][Full Text] [Related]
26. Screening diagnostic candidates for schistosomiasis from tegument proteins of adult Schistosoma japonicum using an immunoproteomic approach.
Zhang M; Fu Z; Li C; Han Y; Cao X; Han H; Liu Y; Lu K; Hong Y; Lin J
PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003454. PubMed ID: 25706299
[TBL] [Abstract][Full Text] [Related]
27. Sera of Schistosoma japonicum-infected patients cross-react with diagnostic 31/32 kD proteins of S. mansoni.
Ruppel A; Shi YE; Wei DX; Diesfeld HJ
Clin Exp Immunol; 1987 Aug; 69(2):291-8. PubMed ID: 3115655
[TBL] [Abstract][Full Text] [Related]
28. Effect of combined treatment with praziquantel and artemether on Schistosoma japonicum and Schistosoma mansoni in experimentally infected animals.
Utzinger J; Chollet J; You J; Mei J; Tanner M; Xiao S
Acta Trop; 2001 Sep; 80(1):9-18. PubMed ID: 11495639
[TBL] [Abstract][Full Text] [Related]
29. Serum levels of circulating anodic antigen and circulating cathodic antigen detected in mice infected with Schistosoma japonicum or S. mansoni.
Van 't Wout AB; De Jonge N; Wood SM; Van Lieshout L; Mitchell GF; Deelder AM
Parasitol Res; 1995; 81(5):434-7. PubMed ID: 7501644
[TBL] [Abstract][Full Text] [Related]
30. Schistosoma mansoni: molecular cloning and sequencing of the 200-kDa chemotherapeutic target antigen.
Hall TM; Joseph GT; Strand M
Exp Parasitol; 1995 Mar; 80(2):242-9. PubMed ID: 7534724
[TBL] [Abstract][Full Text] [Related]
31. Schistosoma japonicum myosin: cloning, expression and vaccination studies with the homologue of the S. mansoni myosin fragment IrV-5.
Zhang Y; Taylor MG; Bickle QD
Parasite Immunol; 1998 Dec; 20(12):583-94. PubMed ID: 9990643
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of recombinant SjLAP and SjFBPA in detecting antibodies to Schistosoma japonicum.
Faustina HL; Luo QL; Zhong ZR; Song XR; Chen ZW; Wang L; Hu MM; Chu DY; Shen JL
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2011 Oct; 29(5):339-47. PubMed ID: 24830194
[TBL] [Abstract][Full Text] [Related]
33. Antibody response to Schistosoma mansoni adult worm cysteine proteinases in infected individuals.
Chappell CL; Dresden MH; Gryseels B; Deelder AM
Am J Trop Med Hyg; 1990 Apr; 42(4):335-41. PubMed ID: 2109948
[TBL] [Abstract][Full Text] [Related]
34. [Advances in immunologic research in schistosomiasis].
Fu Q
Zhonghua Yi Xue Za Zhi; 1990 Sep; 70(9):534-6. PubMed ID: 1964860
[No Abstract] [Full Text] [Related]
35. Detection of circulating antigen in serum of mice infected with Schistosoma japonicum by immunomagnetic bead ELISA based on IgY.
Lei JH; Liu WQ; Sun CS; Tang CL; Li MJ; Chen YL; Li YL
Acta Trop; 2009 Jul; 111(1):39-43. PubMed ID: 19426661
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the use of C-terminal part of the Schistosoma mansoni 200kDa tegumental protein in schistosomiasis diagnosis and vaccine formulation.
Carvalho GB; Pacífico LG; Pimenta DL; Siqueira LM; Teixeira-Carvalho A; Coelho PM; Pinheiro Cda S; Fujiwara RT; Oliveira SC; Fonseca CT
Exp Parasitol; 2014 Apr; 139():24-32. PubMed ID: 24560833
[TBL] [Abstract][Full Text] [Related]
37. Adverse effects of praziquantel treatment of Schistosoma japonicum infection: involvement of host anaphylactic reactions induced by parasite antigen release.
Matsumoto J
Int J Parasitol; 2002 Apr; 32(4):461-71. PubMed ID: 11849642
[TBL] [Abstract][Full Text] [Related]
38. Serodiagnosis of Schistosoma japonicum infection: genome-wide identification of a protein marker, and assessment of its diagnostic validity in a field study in China.
Xu X; Zhang Y; Lin D; Zhang J; Xu J; Liu YM; Hu F; Qing X; Xia C; Pan W
Lancet Infect Dis; 2014 Jun; 14(6):489-97. PubMed ID: 24656567
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of treatment of murine Schistosoma mansoni infections with praziquantel and oxamniquine correlates with infection intensity: role of host antibody.
Fallon PG; Hamilton JV; Doenhoff MJ
Parasitology; 1995 Jul; 111 ( Pt 1)():59-66. PubMed ID: 7609991
[TBL] [Abstract][Full Text] [Related]
40. The possibility of GST antigen from Chinese strain of Schistosoma japonicum for immunodiagnosis of schistosomiasis.
Liu SX; Song GC; Ding LY; Lin ZC; Cai ZH
Southeast Asian J Trop Med Public Health; 1993 Mar; 24(1):70-3. PubMed ID: 8362311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
